130 likes | 305 Views
Presentation Overview. Organizational Issues
E N D
1. TNPP – STATUS REPORTPresentation to the American Plastics Council Sheri Blystone, GE
Robert J. Fensterheim, APERC
January 23, 2001
2. Presentation Overview Organizational Issues – PMC and TNPP Consortium
HPV Test Program
European Union
Implications of EU Assessment of NP
EU Assessment of TNPP
Information Needs
3. Organizational Issues
4. HPV Test Program
5. Robust Summary/Test Plan
6. Status of Activities
7. EU Assessment of
NP and TNPP
8. EU Assessment of NP EU Risk Assessment and Reduction Strategy for NP
Includes restrictions on some uses of NP/NPE
Will not impact TNPP
EU concluded that there are no NP concerns
regarding the production and use of TNPP
9. EU Assessment of TNPP TNPP Added to 4th Priority List; France Rappateur
Alkylphenols & Ethoxylates Research Council lead industry organization
10. TNPP Information Needs for Risk Assess Health and Environmental Effects
- Existing and New Studies
Occupational Exposure
- Provide description of operations to document limited exposure
Environmental Release
- France requested information based on OECD Emissions Scenarios Document (ESD)
ESD is to cover lifecycle of the substance
ESDs are used to estimate local as well as regional exposure concentrations
11. Interaction with France Met with France on two occasions
Submitted robust summaries and available studies
Respond to questions and issues raised regarding the toxicology
Established relationship and survey with APME
12. TNPP Survey Survey developed and distributed by APME
Information sought on:
Imports and exports
Identification of use categories and quantities
Occupational exposure
Environmental Release
13. Cooperative Opportunity b/w APC and TNPP Consortium Develop accurate and positive characterization of the use of TNPP, including human exposure and environmental release
Dispel concerns about TNPP
Promote the use at appropriate industry and governmental forums